LGMC Conducting Research Study on non-Hodgkin’s Lymphoma

7/28/2014

Lafayette General Medical Center is seeking men and women ages 18 and older with B-cell indolent non-Hodgkin’s lymphoma to participate in a clinical trial.

This research study will evaluate medication in adult patients with previously treated indolent non-Hodgkin’s lymphoma.

This is a Phase III clinical trial, which is a final confirmation of safety and efficacy of a treatment. Drugs that successfully pass Phase III are usually approved by the national regulatory authority for use in the general population.

Lafayette General Health participates in clinical trials and studies to help improve patient care and disease prevention. Clinical trials can offer several benefits, such as access to newer treatments and drugs that might not otherwise be available. Trials also help expand knowledge about the best ways to treat cancer.

Clinical trials also empower a patient who may not be responding ideally to treatment to make his or her own decision. Physicians, nurses and other team members at Lafayette General Health facilities will thoroughly instruct a patient on potential risks and benefits of participating in a clinical trial. The staff will then closely monitor and assess the progress of the trial and continue this through follow-up care.

When patients participate in a clinical trial, they are not only advancing medical technology, they are providing a valuable benefit to future generations. The goal of clinical trials at Lafayette General Health is to support the patient-centered approach to health care.

For more information on this and other clinical trials available at Lafayette General Medical Center, call (337) 289-8658 or visit our clinical trials and medical research area.

Back to News Listing